Offerings // OKYO Pharma Ltd

OKYO offering history

Every offering-related filing in OKYO Pharma Ltd’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 306 filings back to Mar 22, 2021.

Last executed offering

Feb 17, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Feb 2, 2026

F-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Feb 17, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 12, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 11, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 10, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 2, 2026	F-3 →	REGISTERED	F-3 registration — capacity to sell shares, not a sale yet
Jun 11, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 20, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 18, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 31, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 15, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 13, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 28, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 28, 2023	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Jun 15, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 14, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 14, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 9, 2023	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Jun 8, 2023	F-3 →	REGISTERED	F-3 registration — capacity to sell shares, not a sale yet
Jun 8, 2023	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Jun 2, 2023	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
May 17, 2023	F-1 →	REGISTERED	F-1 registration — capacity to sell shares, not a sale yet
Mar 14, 2023	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Mar 8, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 27, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 22, 2023	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Feb 17, 2023	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Jan 19, 2023	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Jan 19, 2023	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Jan 12, 2023	RW →	WITHDRAWN	Registration withdrawn
Jan 3, 2023	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Jan 3, 2023	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Dec 9, 2022	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Dec 9, 2022	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Dec 6, 2022	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Dec 5, 2022	F-1 →	REGISTERED	F-1 registration — capacity to sell shares, not a sale yet
May 18, 2022	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
May 16, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 16, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 13, 2022	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
May 13, 2022	FWP →	MARKETING	Free-writing prospectus — offering being marketed

OKYO offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full OKYO workspace →

OKYO offering FAQ

When did OKYO last execute an offering?

Per SEC filings, OKYO Pharma Ltd's most recent priced offering document is a 424B5 filed 2026-02-17. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did OKYO last announce or register an offering?

The most recent registration is a F-3 filed 2026-02-02. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.